Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.39
- Piotroski Score 7.00
- Grade Outperform
- Symbol (VMD)
- Company Viemed Healthcare, Inc.
- Price $7.32
- Changes Percentage (0.41%)
- Change $0.03
- Day Low $7.21
- Day High $7.38
- Year High $10.44
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/29/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.25
- Trailing P/E Ratio 28.8
- Forward P/E Ratio 28.8
- P/E Growth 28.8
- Net Income $10.24 M
Income Statement
Quarterly
Annual
Latest News of VMD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Revolution Medicines, Inc. (RVMD): Among Hedge Funds' Top Biotech Stock Picks
A list of the 10 largest biotech hedge funds and their top stock picks was compiled, focusing on Revolution Medicines, Inc. (NASDAQ:RVMD) and its position among biotech stocks....
By Yahoo! Finance | 2 weeks ago -
Revolution Medicines, Inc. (RVMD) Stock Price, News, Quote & History - Yahoo Finance
Revolution Medicines, Inc. is a precision oncology company developing targeted therapies for RAS-addicted cancers. They have a pipeline of RAS(ON) inhibitors and companion inhibitors for combination t...
By Yahoo! Finance | 2 months ago -
Insider Sale: COO Margaret Horn Sells Shares of Revolution Medicines Inc (RVMD)
Margaret Horn, COO of Revolution Medicines Inc, sold 4,415 shares at $37.39 each, totaling 93,609 shares sold in a year....
By Yahoo! Finance | 3 months ago
